{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00857779",
      "orgStudyIdInfo": {
        "id": "AF-H-01"
      },
      "organization": {
        "fullName": "ALK-Abelló A/S",
        "class": "INDUSTRY"
      },
      "briefTitle": "Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients",
      "officialTitle": "A Multicentre Randomised Phase II Clinical Trial to Demonstrate Equivalent Pharmacodynamic Efficacy and Tolerability of Two Updosing Schedules for ALK-Flex SQ"
    },
    "statusModule": {
      "statusVerifiedDate": "2013-02",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2009-02"
      },
      "primaryCompletionDateStruct": {
        "date": "2009-08",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2009-10",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2009-03-05",
      "studyFirstSubmitQcDate": "2009-03-05",
      "studyFirstPostDateStruct": {
        "date": "2009-03-09",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2013-02-07",
      "lastUpdatePostDateStruct": {
        "date": "2013-02-08",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "ALK-Abelló A/S",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true
    },
    "descriptionModule": {
      "briefSummary": "The aim of this study is to test the pharmacodynamic equivalence with respect to IgE-blocking factor and to compare the tolerability of two different updosing schedules with ALK-Flex SQ"
    },
    "conditionsModule": {
      "conditions": [
        "Rhinitis",
        "Conjunctivitis",
        "Asthma"
      ],
      "keywords": [
        "allergen immunotherapy",
        "allergy to grass pollen"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 473,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "subcutaneous immunotherapy",
          "type": "ACTIVE_COMPARATOR",
          "description": "subcutaneous immunotherapy using a slow updosing schedule",
          "interventionNames": [
            "Biological: subcutaneous immunotherapy"
          ]
        },
        {
          "label": "subcutaneous injections",
          "type": "ACTIVE_COMPARATOR",
          "description": "subcutaneous immunotherapy using a fast updosing schedule",
          "interventionNames": [
            "Biological: subcutaneous immunotherapy"
          ]
        }
      ],
      "interventions": [
        {
          "type": "BIOLOGICAL",
          "name": "subcutaneous immunotherapy",
          "description": "7 injections",
          "armGroupLabels": [
            "subcutaneous immunotherapy",
            "subcutaneous injections"
          ],
          "otherNames": [
            "AVANZ"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "IgE-blocking factor",
          "timeFrame": "start of treatment and 1 week after end of treatment"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Tolerability of two different updosing schedules",
          "timeFrame": "throughout treatment"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* A clinical history of grass pollen induced allergic rhinoconjunctivitis of two years or more requiring treatment during the grass pollen season\n* Lack of adequate relief with symptomatic medication during the previous grass pollen season\n* Positive Skin Prick Test (SPT) response to Phleum pratense (wheal diameter \\>= 3mm) currently performed or not older than 60 days before screening\n\nExclusion Criteria:\n\n* FEV1 \\< 70% of predicted value at screening\n* Bronchial asthma corresponding to GINA step 3 or more, even if controlled\n* History of asthma exacerbation or emergency visit or admission for asthma in the previous 12 months\n* Previous treatment by immunotherapy with grass pollen allergen or any other allergen within the previous 5 years\n* Exclusion criteria in accordance with contraindications in the SPC of ALK-Flex SQ",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "65 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Kirsten Jung, MD",
          "affiliation": "Private practice, Erfurt, Germany",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Allergists' practice Dr. Kirsten Jung",
          "city": "Erfurt",
          "state": "Thuringia",
          "zip": "D-99084",
          "country": "Germany",
          "geoPoint": {
            "lat": 50.97734,
            "lon": 11.03536
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "22385366",
          "type": "RESULT",
          "citation": "Pfaar O, Jung K, Wolf H, Decot E, Kleine-Tebbe J, Klimek L, Wustenberg E. Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio. Allergy. 2012 May;67(5):630-7. doi: 10.1111/j.1398-9995.2012.02801.x. Epub 2012 Mar 3."
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D012220",
          "term": "Rhinitis"
        },
        {
          "id": "D003231",
          "term": "Conjunctivitis"
        },
        {
          "id": "D001249",
          "term": "Asthma"
        }
      ],
      "ancestors": [
        {
          "id": "D012141",
          "term": "Respiratory Tract Infections"
        },
        {
          "id": "D007239",
          "term": "Infections"
        },
        {
          "id": "D009668",
          "term": "Nose Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D010038",
          "term": "Otorhinolaryngologic Diseases"
        },
        {
          "id": "D003229",
          "term": "Conjunctival Diseases"
        },
        {
          "id": "D005128",
          "term": "Eye Diseases"
        },
        {
          "id": "D001982",
          "term": "Bronchial Diseases"
        },
        {
          "id": "D008173",
          "term": "Lung Diseases, Obstructive"
        },
        {
          "id": "D008171",
          "term": "Lung Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    }
  },
  "hasResults": false
}